News Tagged ‘colon screenings

Blood test to detect colon cancer seeks FDA approval

blood testYet another biotech company is diligently working to find a safer, less invasive test besides a colonoscopy to detect cancers of the colon and rectum. EDP Biotech Corporation of West Knoxville, Tenn., has announced that it is seeking FDA approval of a blood test to detect colon cancer at its earliest and most treatable stages.

Read the rest of this entry »

Less invasive alternative to colonoscopy set for 2011 clinical trial

colorectal cancersA Madison, Wis., company is developing a less invasive way of screening for colon cancer that it hopes will take the place of uncomfortable colonoscopies and increase the number of people willing to be screened for colorectal cancers. Exact Sciences Corp., has developed a DNA-based test that can detect colorectal cancer through a stool sample. Even more convenient than a colonoscopy for the patient, the test can be administered at home and sent to a lab for analysis.

Read the rest of this entry »

New test can identify kidney injury earlier

kidney diagramEach year, more than 13 million patients suffer from acute kidney injury, of which more than 30 percent die. The prevalence of kidney injury has risen to epidemic proportions. Over the past 60 years, little progress has been made to improve the statistics of this condition. But Denmark-based company BioPorto Diagnostics has developed a groundbreaking test called NGAL that can diagnose acute kidney injury early, adding valuable time for doctors to take proactive steps at an early stage that will prevent kidney injury from turning into the very dangerous state of kidney failure.

Read the rest of this entry »

Vaccine may eliminate need for routine colon screenings

vaccine 150x150 Vaccine may eliminate need for routine colon screeningsClinical trials of a vaccine designed to trigger the body to attack a protein linked to colon cancer are currently being conducted by scientists at the University of Pittsburgh School of Medicine. The vaccine activates the immune system to target a defective protein which is prevalent in colorectal cancer tissue and other precancerous tissues. Researchers hope, if proven successful, the vaccine may eliminate the need for repeated colon screenings in high-risk patients. These patients tend to have multiple precancerous polyps, called advanced adenomas, in their intestines. Routine colonoscopies look for signs of recurrence of the polyps.

Read the rest of this entry »